Some Breast Cancer Patients May Not Need Post-Op Chest Wall Radiation
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Dec. 18, 2024 -- Radiation therapy for breast cancer comes with a host of side effects, including conditions as serious as heart problems and pneumonia.
Now, a new study says some breast cancer patients can safely skip radiation therapy without risking their cancer coming back.
Women who didn’t get radiation following a mastectomy had similar rates of 10-year survival as those who did get radiation, according to results from the BIG 2-04 MRC SUPREMO clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS) in December.
“This study demonstrates that chest wall irradiation after a mastectomy has no influence on 10-year overall survival for patients with intermediate-risk breast cancer,” researcher Ian Kunkler, a professor of clinical oncology at the University of Edinburgh in Scotland, said in an SABCS news release.
Post-mastectomy chest wall irradiation is the standard of care for most patients with early-stage breast cancer that’s spread to four or more lymph nodes, Kunkler explained.
Chest wall irradiation is meant to prevent recurrence of breast cancer by killing off tumor cells that might have spread to other locations in the chest.
However, the role of chest wall irradiation in patients with fewer than four cancerous lymph notes remains controversial, Kunkler emphasized.
Chest wall irradiation is commonly used to treat patients with three or fewer cancerous lymph nodes if they have other factors that increase the recurrence of their breast cancer, Kunkler added.
For this clinical trial, researchers enrolled more than 1,600 patients with early-stage breast cancer. About half were randomly assigned to receive chest wall irradiation (CWI) following mastectomy, and the other half did not get radiation therapy.
There wound up being no significant differences in overall survival between the two groups -- 81% for those who got radiation and 82% for those who didn’t after about 10 years of follow-up.
Kunkler noted that the absolute rate of cancer recurrence in patients’ chest walls was reduced by less than 2%, a clinically insignificant difference.
There weren’t any benefits to patients whose cancer had spread to their lymph nodes, researchers found.
“The results are important considerations for shared decision-making conversations between patients and clinicians, as many patients eligible for post-mastectomy CWI [chest radiation] may not require the treatment,” Kunkler concluded.
It's important to note that findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-19 00:00
Read more
- PREVENT Equations Classify 15 Million at Elevated Risk for Heart Failure
- Two Common Antiseizure Medications Do Not Harm Child Neurodevelopment
- Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer
- Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas
- Antiobesity Medications Tied to Decreased Alcohol Use
- Irregular Sleep Linked to Increased Risk for Major Adverse Cardiovascular Events
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions